C. H. Bunker, E. L. Berson, W. C. Bromley, R. P. Hayes, and T. H. Roderick, Prevalence of retinitis pigmentosa in Maine, Am J Ophthalmol. mars, vol.97, issue.3, pp.357-65, 1984.

J. Grøndahl, Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway, Clin Genet. avr, vol.31, issue.4, pp.255-64, 1987.

C. Nájera, J. M. Millán, M. Beneyto, and F. Prieto, Epidemiology of retinitis pigmentosa in the Valencian community (Spain), Genet Epidemiol, vol.12, issue.1, pp.37-46, 1995.

M. Haim, Epidemiology of retinitis pigmentosa in Denmark, Acta Ophthalmol Scand Suppl, issue.233, pp.1-34, 2002.

J. P. Szlyk, W. Seiple, G. A. Fishman, K. R. Alexander, S. Grover et al., Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa, Ophthalmology. janv, vol.108, issue.1, pp.65-75, 2001.

S. Nakagawa, A. Oishi, K. Ogino, Y. Makiyama, M. Kurimoto et al., Association of retinal vessel attenuation with visual function in eyes with retinitis pigmentosa, Clin Ophthalmol, vol.8, pp.1487-93, 2014.

Z. Y. Li, D. E. Possin, and A. H. Milam, Histopathology of bone spicule pigmentation in retinitis pigmentosa, Ophthalmology. mai, vol.102, issue.5, pp.805-821, 1995.

M. F. Marmor, The electroretinogram in retinitis pigmentosa, Arch Ophthalmol. juill, vol.97, issue.7, pp.1300-1304, 1979.

E. L. Berson, Electroretinographic findings in retinitis pigmentosa, Jpn J Ophthalmol, vol.31, issue.3, pp.327-375, 1987.

A. Iannaccone, E. Rispoli, E. M. Vingolo, P. Onori, K. Steindl et al., Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa, Doc Ophthalmol, vol.90, issue.2, pp.129-171, 1995.

E. L. Berson, B. Rosner, M. A. Sandberg, K. C. Hayes, B. W. Nicholson et al., A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa, Arch Ophthalmol. juin, vol.111, issue.6, pp.761-72, 1993.

M. A. Sandberg, R. J. Brockhurst, A. R. Gaudio, and E. L. Berson, The association between visual acuity and central retinal thickness in retinitis pigmentosa, Invest Ophthalmol Vis Sci. sept, vol.46, issue.9, pp.3349-54, 2005.

C. H. Moon, T. K. Park, and Y. Ohn, Association between multifocal electroretinograms, optical coherence tomography and central visual sensitivity in advanced retinitis pigmentosa, Doc Ophthalmol, vol.125, issue.2, pp.113-135, 2012.

J. Chhablani, G. B. Jonnadula, S. Rao, P. Venkata, A. Jalali et al., Choroidal thickness profile in Retinitis Pigmentosa -Correlation with outer retinal structures, Saudi J Ophthalmol. mars, vol.30, issue.1, pp.9-13, 2016.

K. Konieczka, R. I. Bojinova, C. Valmaggia, D. F. Schorderet, M. G. Todorova et al., Preserved functional and structural integrity of the papillomacular area correlates with better visual acuity in retinitis pigmentosa. Eye (Lond), vol.30, pp.1310-1333, 2016.

H. Chung, J. Hwang, J. Kim, and Y. H. Yoon, Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa, Retina, vol.26, issue.8, pp.922-929, 2006.

D. T. Hartong, E. L. Berson, and T. P. Dryja, Retinitis pigmentosa. Lancet, vol.368, pp.1795-809, 2006.

F. C. Mansergh, S. Millington-ward, A. Kennan, A. S. Kiang, M. Humphries et al., Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene, Am J Hum Genet. avr, vol.64, issue.4, pp.971-85, 1999.

K. Kajiwara, E. L. Berson, and T. P. Dryja, Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci, Science. 10 juin, vol.264, issue.5165, pp.1604-1612, 1994.

M. L. Naash, N. S. Peachey, Z. Y. Li, C. C. Gryczan, Y. Goto et al., Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin, Invest Ophthalmol Vis Sci. avr, vol.37, issue.5, pp.775-82, 1996.

C. Hamel and . Retinitis, Orphanet J Rare Dis, vol.1, p.40, 2006.

S. J. Fliesler and R. E. Anderson, Chemistry and metabolism of lipids in the vertebrate retina, Prog Lipid Res, vol.22, issue.2, pp.79-131, 1983.

D. R. Hoffman, K. G. Locke, D. H. Wheaton, G. E. Fish, R. Spencer et al., A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa, Am J Ophthalmol. avr, vol.137, issue.4, pp.704-722, 2004.

E. L. Berson, B. Rosner, M. A. Sandberg, C. Weigel-difranco, A. Moser et al., Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment, Arch Ophthalmol. sept, vol.122, issue.9, pp.1297-305, 2004.

E. L. Berson, B. Rosner, M. A. Sandberg, C. Weigel-difranco, A. Moser et al., Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses, Arch Ophthalmol. sept, vol.122, issue.9, pp.1306-1320, 2004.

G. A. Fishman, L. D. Gilbert, R. G. Fiscella, A. E. Kimura, and L. M. Jampol, Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa, Arch Ophthalmol, vol.107, issue.10, pp.1445-52, 1989.

S. Grover, G. A. Fishman, R. G. Fiscella, and A. E. Adelman, Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa, Retina, vol.17, issue.3, pp.222-253, 1997.

S. J. Ahn, K. E. Kim, S. J. Woo, and K. H. Park, The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review, Ophthalmic Surg Lasers Imaging Retina. avr, vol.45, issue.2, pp.160-164, 2014.

G. Moustafa and M. M. Moschos, Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa -a first case report and short review of the literature, BMC Ophthalmol. 30 avr, vol.15, p.44, 2015.

G. M. Acland, G. D. Aguirre, J. Ray, Q. Zhang, T. S. Aleman et al., Gene therapy restores vision in a canine model of childhood blindness, Nat Genet. mai, vol.28, issue.1, pp.92-97, 2001.

S. Russell, J. Bennett, J. A. Wellman, D. C. Chung, Z. Yu et al., Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial, Lancet. 26 août, vol.390, pp.849-60, 2017.

A. R. Caffé, A. K. Söderpalm, I. Holmqvist, and T. Van-veen, A combination of CNTF and BDNF rescues rd photoreceptors but changes rod differentiation in the presence of RPE in retinal explants, Invest Ophthalmol Vis Sci. janv, vol.42, issue.1, pp.275-82, 2001.

M. Delyfer, M. Simonutti, N. Neveux, T. Léveillard, and J. Sahel, Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST?, Mol Vis. 1 sept, vol.11, pp.677-87, 2005.

Y. Uteza, J. S. Rouillot, A. Kobetz, D. Marchant, S. Pecqueur et al., Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats, Proc Natl Acad Sci, vol.96, issue.6, pp.3126-3157, 1999.

D. G. Birch, L. D. Bennett, J. L. Duncan, R. G. Weleber, and M. E. Pennesi, Long-term Followup of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants, Am J Ophthalmol. oct, vol.170, pp.10-14, 2016.

R. K. Singh, L. M. Occelli, F. Binette, P. Simon, and I. Nasonkin, Transplantation of human embryonic stem cell derived retinal tissue in the subretinal space of the cat eye, Stem Cells Dev. 18 juin, 2019.

H. Lorach, S. Kang, M. B. Bhuckory, A. Trouillet, R. Dalal et al., Transplantation of Mature Photoreceptors in Rodents With Retinal Degeneration, Transl Vis Sci Technol. mai, vol.8, issue.3, p.30, 2019.

T. Léveillard and L. Klipfel, Mechanisms Underlying the Visual Benefit of Cell Transplantation for the Treatment of Retinal Degenerations, Int J Mol Sci. 28 janv, vol.20, issue.3, 2019.

A. L. Hodgkin and A. F. Huxley, Propagation of electrical signals along giant nerve fibers, Proc R Soc Lond, B, Biol Sci, vol.140, issue.899, pp.177-83, 1952.

G. S. Brindley and W. S. Lewin, The sensations produced by electrical stimulation of the visual cortex, J Physiol (Lond). mai, vol.196, issue.2, pp.479-93, 1968.

R. Fernandes, B. Diniz, R. Ribeiro, and M. Humayun, Artificial vision through neuronal stimulation, Neurosci Lett. 25 juin, vol.519, issue.2, pp.122-130, 2012.

Y. Luo and L. Da-cruz, The Argus(®) II Retinal Prosthesis System, Prog Retin Eye Res. janv, vol.50, pp.89-107, 2016.

S. B. Brummer, J. Mchardy, and M. J. Turner, Electrical stimulation with Pt electrodes: Trace analysis for dissolved platinum and other dissolved electrochemical products, Brain Behav Evol. févr, vol.14, issue.1-2, pp.10-22, 1977.

E. Zrenner, Fighting blindness with microelectronics, Sci Transl Med, vol.5, issue.210, pp.210-226, 2013.

M. Delyfer, D. Gaucher, M. Govare, A. Cougnard-grégoire, J. Korobelnik et al., Adapted Surgical Procedure for Argus II Retinal Implantation: Feasibility, Safety, Efficiency, and Postoperative Anatomic Findings, Ophthalmol Retina. avr, vol.2, issue.4, pp.276-87, 2018.

S. K. Verbakel, R. Van-huet, C. Boon, A. I. Hollander, R. Collin et al., Non-syndromic retinitis pigmentosa, Prog Retin Eye Res, vol.66, pp.157-86, 2018.

V. Takahashi, J. T. Takiuti, R. Jauregui, L. H. Lima, and S. H. Tsang, Structural disease progression in PDE6-associated autosomal recessive retinitis pigmentosa, Ophthalmic Genet, vol.39, issue.5, pp.610-614, 2018.

M. S. Humayun, E. De-juan, and G. Dagnelie, The Bionic Eye: A Quarter Century of Retinal Prosthesis Research and Development, Ophthalmology, vol.123, issue.10S, pp.89-97, 2016.

J. O. Mills, A. Jalil, and P. E. Stanga, Electronic retinal implants and artificial vision: journey and present. Eye (Lond), vol.31, pp.1383-98, 2017.

L. Da-cruz, J. D. Dorn, M. S. Humayun, G. Dagnelie, J. Handa et al., Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial, Ophthalmology, vol.123, issue.10, pp.2248-54, 2016.

S. Rizzo, L. Cinelli, L. Finocchio, R. Tartaro, F. Santoro et al., Assessment of Postoperative Morphologic Retinal Changes by Optical Coherence Tomography in Recipients of an Electronic Retinal Prosthesis Implant, JAMA Ophthalmol. 3 janv, 2019.

F. Patelli, L. Colombo, M. Aly, L. Rossetti, . Anatomical et al., FIRST YEAR: A CASE REPORT, 2018.

K. Schaffrath, H. Schellhase, P. Walter, A. A. Chizzolini, M. Kirchhof et al., One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study, JAMA Ophthalmol. 30 mai, 2019.

N. Z. Gregori, N. F. Callaway, C. Hoeppner, A. Yuan, A. Rachitskaya et al., Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study, Am J Ophthalmol. sept, vol.193, pp.87-99, 2018.

F. Ando and J. Kondo, A plastic tack for the treatment of retinal detachment with giant tear, Am J Ophthalmol. févr, vol.95, issue.2, pp.260-261, 1983.

E. De-juan, D. Hickingbotham, R. Machemer, and . Tacks, Am J Ophthalmol. 15 mars, vol.99, issue.3, pp.272-276, 1985.

A. K. Ahuja, J. Yeoh, J. D. Dorn, A. Caspi, V. Wuyyuru et al., Factors Affecting Perceptual Threshold in Argus II Retinal Prosthesis Subjects, Transl Vis Sci Technol. avr, vol.2, issue.4, p.1, 2013.

D. H. Ghodasra, A. Chen, J. F. Arevalo, D. G. Birch, K. Branham et al., Worldwide Argus II implantation: recommendations to optimize patient outcomes, BMC Ophthalmol. 6 mai, vol.16, p.52, 2016.

M. I. Seider and P. Hahn, Argus II retinal prosthesis malrotation and repositioning with intraoperative optical coherence tomography in a posterior staphyloma, Clin Ophthalmol, vol.9, pp.2213-2219, 2015.

M. Wilk, R. Hessler, K. Mugridge, C. Jolly, M. Fehr et al., Impedance Changes and Fibrous Tissue Growth after Cochlear Implantation Are Correlated and Can Be Reduced Using a Dexamethasone Eluting Electrode, PLoS ONE, vol.11, issue.2, p.147552, 2016.

A. C. Ho, M. S. Humayun, J. D. Dorn, L. Da-cruz, G. Dagnelie et al., Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind, Ophthalmology. août, vol.122, issue.8, pp.1547-54, 2015.

D. R. Geruschat, M. Flax, N. Tanna, M. Bianchi, A. Fisher et al., FLORA TM : Phase I development of a functional vision assessment for prosthetic vision users, Clin Exp Optom. juill, vol.98, issue.4, pp.342-349, 2015.

. Serment-d'hippocrate,

, Au moment d'etre admis a? exercer la medecine, je promets et je jure d'etre fidele aux lois de l'honneur et de la probite

, Mon premier souci sera de retablir, de pre?erver ou de promouvoir la sante? dans tous ses e?e?ents, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonte, sans aucune discrimination selon leur etat ou leurs convictions. J'interviendrai pour les prote?er si elles sont affaiblies, vulne?ables ou menaceés dans leur inte?rite? ou leur dignite. Meme sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir he?ite? des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Recu a? l'inte?ieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas a? corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort de?ibe?e?ent

, Je n'entreprendrai rien qui de?asse mes competences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demande?

, J'apporterai mon aide a? mes confreres ainsi qu'a? leurs familles dans l'adversite

, Que les hommes et mes confreres m'accordent leur estime si je suis fidele a? mes promesses ; que je sois de?honore? et me?rise? si j'y manque